Ligand Pharmaceuticals: Janus Henderson owns 4.6%
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Ligand Pharmaceuticals Incorporated (LGND) is the subject of Janus Henderson Group Ltd.'s amended report of beneficial ownership: 914,350 common shares, or 4.6% of the class. Janus Henderson reports shared voting and dispositive power over all 914,350 shares.
Key Figures
Beneficially owned common shares: 914,350 shares
Percent of class: 4.6%
Shared voting power: 914,350 shares
+3 more
6 metrics
Beneficially owned common shares
914,350 shares
Janus Henderson Group Ltd. report
Percent of class
4.6%
914,350 shares beneficially owned
Shared voting power
914,350 shares
Janus Henderson Group Ltd. report
Shared dispositive power
914,350 shares
Janus Henderson Group Ltd. report
Sole voting power
0 shares
Janus Henderson Group Ltd. report
Sole dispositive power
0 shares
Janus Henderson Group Ltd. report
Key Terms
beneficially owned, shared voting power, shared dispositive power, Managed Portfolios
4 terms
beneficially owned regulatory
"securities beneficially owned, or deemed to be beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Managed Portfolios financial
"collectively referred to herein as Managed Portfolios"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does any Managed Portfolio own more than 5% of LGND?
None of the Managed Portfolios owns more than 5% of Ligand Pharmaceuticals common stock. The portfolios hold the shares in their respective accounts and have the right to receive dividends and proceeds from sales.
AI-generated analysis. How Rhea-AI works. Not financial advice.